The drug from the common cold :: Consumers survey results of 2012

Consumers survey results of 2012 in category

Cold and Flu / The drug from the common cold

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Піносол (Zentiva)	28.79%	5

2.		Назол (Bayer)	21.21%	3.86

3.	7	Синупрет (Bionorica)	16.67%	3.41

4.	6	Aqua Maris (Jadran)	18.18%	3.27

5.	4	Нокспрей (Сперко Україна)	15.15%	2.86

5.	16	Отривін (Novartis OTC)	13.64%	2.86

7.	3	Nasivin (Dr. Reddy’s)	13.64%	2.82

8.		Віброцил (Novartis OTC)	13.64%	2.41

9.	23	Назалонг (Валартін Фарма)	10.61%	1.73

10.	9	Риназолін (Farmak)	7.58%	1.50

11.	9	Нафтизин (Farmak)	9.09%	1.45

12.		Евказолін Аква (Farmak)	7.58%	1.41

12.	11	Фармазолін (Farmak)	9.09%	1.41

14.	13	Длянос (Novartis OTC)	6.06%	1.18

–.	28	~~Актифед (GlaxoSmithKline)~~	~~4.55%~~	~~0.95~~

15.	10	Делуфен (Perrigo)	6.06%	0.95

15.	20	Цинабсин (DHU)	4.55%	0.95

17.	19	Tyzine (Johnson & Johnson)	4.55%	0.68

18.	21	Галазолін (ICN Polfa Rzeszow)	3.03%	0.45

18.	26	Каметон (Стома)	3.03%	0.45

18.	5	Санорин (Teva)	3.03%	0.45

18.	14	Спрей назальний др. Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	3.03%	0.45

22.		Асініс (Perrigo)	1.52%	0.27

22.	18	Мілістан Сінус (Mili Healthcare)	1.52%	0.27

22.	15	Но-соль (Farmak)	1.52%	0.27

25.	33	Ксилометазолін (ICN Polfa Rzeszow)	1.52%	0.23

25.	31	Риностоп (Bosnalijek)	1.52%	0.23

–.	27	Аллертек (ICN Polfa Rzeszow)	0.00%	0

–.	30	Гайморин (Національна гомеопатична спілка)	0.00%	0

–.	33	Грипостад Ріно (Nizhpharm)	0.00%	0

–.	24	Ксилогексал (Sandoz)	0.00%	0

–.	25	Назолін-Дарниця (Darnitsa)	0.00%	0

–.	33	Ноксивін (Фармтехнологія)	0.00%	0

–.	34	Орінол плюс (Bayer)	0.00%	0

–.	30	Піновіт (Farmak)	0.00%	0

–.	32	Ріназал (Darnitsa)	0.00%	0

–.	33	СНУП (Stada)	0.00%	0

–.	17	Салін (Bayer)	0.00%	0

–.	29	Трайфед (Hikma)	0.00%	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2012, recommendation of consumers #1 in the category “The drug from the common cold”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2012, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.